Skye Bioscience (SKYE) Institutional Ownership $3.01 -0.24 (-7.38%) (As of 04:00 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Skye Bioscience (NASDAQ:SKYE)CurrentInstitutional OwnershipPercentage21.09%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$72.20MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.12M Get SKYE Insider Trade Alerts Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SKYE Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Skye Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC57,889$226K0.0%+36.7%0.191% 11/16/2024 Geode Capital Management LLC385,793$1.51M0.0%+4.2%1.272% 11/15/2024 Barclays PLC57,889$226K0.0%+36.7%0.191% 11/15/2024 Jane Street Group LLC12,200$48K0.0%N/A0.040% 11/15/2024 Sphera Funds Management LTD.1,563,522$6.11M1.0%+20.4%5.153% 11/15/2024 State Street Corp354,205$1.39M0.0%+7.0%1.167% 11/15/2024 Point72 Asset Management L.P.416,424$1.63M0.0%-25.6%1.373% 11/15/2024 Baker BROS. Advisors LP1,434,634$5.61M0.1%+186.9%4.729% 11/13/2024 BNP Paribas Financial Markets47,417$185K0.0%+71.1%0.156% 9/16/2024 Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 9/16/2024 Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 9/16/2024 Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/19/2024 Point72 Asset Management L.P.560,000$4.49M0.0%N/A1.995% 8/16/2024 Perceptive Advisors LLC500,000$4.01M0.1%N/A1.781% 8/16/2024 Driehaus Capital Management LLC650,758$5.21M0.0%N/A2.319% 8/15/2024CVI Holdings LLC679,739$5.45M4.9%N/A2.422% 8/15/2024 Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/14/2024 Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 8/14/2024 Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 8/14/2024 Logos Global Management LP1,301,518$10.43M0.8%N/A4.637% 8/8/2024 AdvisorShares Investments LLC26,000$210K0.0%N/A0.093% 8/1/2024 Rhumbline Advisers19,754$158K0.0%N/A0.070% 7/26/2024 Bank of New York Mellon Corp58,778$471K0.0%N/A0.209% (Data available from 1/1/2016 forward) SKYE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SKYE shares? During the previous two years, 18 institutional investors and hedge funds held shares of Skye Bioscience. The most heavily invested institutionals were Logos Global Management LP ($10.43M), Sphera Funds Management LTD. ($6.11M), Baker BROS. Advisors LP ($5.61M), CVI Holdings LLC ($5.45M), Driehaus Capital Management LLC ($5.21M), Perceptive Advisors LLC ($4.01M), and Point72 Asset Management L.P. ($1.63M).Learn more on SKYE's institutional investors. What percentage of Skye Bioscience stock is owned by institutional investors? 21.09% of Skye Bioscience stock is owned by institutional investors. Learn more on SKYE's institutional investor holdings. Which institutional investors have been buying Skye Bioscience stock? Of the 18 institutional investors that purchased Skye Bioscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Logos Global Management LP ($1.30M), Baker BROS. Advisors LP ($934.63K), CVI Holdings LLC ($679.74K), Driehaus Capital Management LLC ($650.76K), Point72 Asset Management L.P. ($560K), Perceptive Advisors LLC ($500K), and Sphera Funds Management LTD. ($265.21K). How much institutional buying is happening at Skye Bioscience? Institutional investors have bought a total of 5,173,272 shares in the last 24 months. This purchase volume represents approximately $72.20M in transactions. Which Skye Bioscience major shareholders have been selling company stock? The following institutional investors have sold Skye Bioscience stock in the last 24 months: Point72 Asset Management L.P. ($143.58K). How much institutional selling is happening at Skye Bioscience? Institutional investors have sold a total of 143,576 shares in the last 24 months. This volume of shares sold represents approximately $1.12M in transactions. Related Companies CYRX Major Shareholders NGNE Major Shareholders BTMD Major Shareholders DSGN Major Shareholders VYGR Major Shareholders CTNM Major Shareholders SLRN Major Shareholders KMDA Major Shareholders CGC Major Shareholders TRVI Major Shareholders This page (NASDAQ:SKYE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SKYE Stock Alerts